Ensign Peak Advisors, Inc Mirati Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $1.45 Million - $2.37 Million	52,215 Added 272.81%	71,355 $3.11 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $113,809 - $155,893	3,150 Added 19.7%	19,140 $691,000
Q4 2022 Feb 13, 2023	SELL	$41.27 - $98.62 $3.16 Million - $7.56 Million	-76,627 Reduced 82.74%	15,990 $724,000
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $55,121 - $109,755	727 Added 0.79%	92,617 $7.62 Million
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $1.87 Million - $2.7 Million	14,183 Added 18.25%	91,890 $13.5 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $3.81 Million - $5.12 Million	28,835 Added 59.0%	77,707 $13.7 Million
Q2 2021 Aug 13, 2021	BUY	$144.0 - $179.73 $3.19 Million - $3.98 Million	22,135 Added 82.79%	48,872 $7.89 Million
Q1 2021 May 12, 2021	BUY	$158.92 - $221.61 $1.06 Million - $1.48 Million	6,663 Added 33.19%	26,737 $4.58 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $1.79 Million - $2.65 Million	-11,034 Reduced 35.47%	20,074 $4.41 Million
Q3 2020 Nov 12, 2020	BUY	$113.26 - $167.27 $835,179 - $1.23 Million	7,374 Added 31.07%	31,108 $5.17 Million
Q2 2020 Aug 12, 2020	SELL	$72.01 - $120.39 $201,483 - $336,851	-2,798 Reduced 10.55%	23,734 $2.71 Million
Q1 2020 May 11, 2020	BUY	$69.78 - $116.21 $1.65 Million - $2.75 Million	23,632 Added 814.9%	26,532 $2.04 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $205,204 - $373,694	2,900 New	2,900 $373,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.